|
Elena's Biotech Briefing
Distilled Bio uses AI to process and generate content for you. Verify important details using the linked sources.
AI-generated briefing: Basecamp Research raises $140 million for AI-designed drugs, China sets biopharma ambitions, and Eli Lilly commits up to $3.35 billion to a new alliance.
The top 10 stories from Thu Sep 24, 2026 06:47 AM to Fri Sep 25, 2026 06:47 AM
Generated September 25, 2026 at 6:47 AM
|
|
|
#1 XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain Published 2026-09-25 XtalPi submitted a U.S. FDA investigational new drug application for KQTD-126, a gut-restricted pan-TRK inhibitor being developed for chronic intestinal pain. Covered by: prnewswire.com |
#2 Network Bio: Building disease-specific AI models with biobank data Published 2026-09-25 Palo Alto-based Network Bio uses patient-derived tissue biobank data to develop disease-specific AI models aimed at tracking disease progression and enabling earlier detection and treatment. Covered by: biocentury.com |
#3 ACROBiosystems Introduces CHO-Direct and ACRO AIx to Accelerate AI-driven Drug Discovery Published 2026-09-24 ACROBiosystems introduced ACRO AIx, CHO-Direct, and GlobalLifeShip, targeting AI-driven drug discovery and cross-border biopharmaceutical supply chains. Covered by: prnewswire.com |
#4 Backed by NVIDIA and Anthropic, Basecamp bags $140M to advance AI-designed drugs Published 2026-09-24 Basecamp Research raised $140 million from investors including NVIDIA and Anthropic to advance AI-designed drugs. Covered by: biospace.com, prnewswire.com, biocentury.com |
#5 Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop Therapeutic Bispecific Antibodies in Oncology Published 2026-09-24 Earendil Labs announced a research collaboration with Genentech to discover and develop multiple therapeutic bispecific antibodies for oncology. Covered by: prnewswire.com, endpoints.news |
#6 STAT+: In radiology, AI is blurring the line between technology development and clinical practice Published 2026-09-24 Radiology practices, especially outpatient and teleradiology groups, are developing and deploying AI tools in-house, despite Geoffrey Hinton’s prediction that AI would soon replace radiologists. Covered by: statnews.com |
#7 Simcere Envisions World-Facing R&D To Scale Up Global Partnerships Published 2026-09-24 Simcere plans to expand its global partnerships through a world-facing research and development strategy supporting future licensing deals. Covered by: insights.citeline.com |
#8 Global Bioinformatics Market to Reach USD 64.60 Billion by 2034, Driven by AI, Genomics, Next-Generation Sequencing, and Precision Medicine Report Maximize Market Research Published 2026-09-24 The global bioinformatics market was valued at $20.34 billion in 2025 and is projected to reach $64.60 billion by 2034, growing at a 13.7% CAGR. Covered by: prnewswire.com |
#9 Lilly’s latest China drug deal; Immunovant’s setback in lupus Published 2026-09-24 Eli Lilly entered its fourth China-focused alliance since January 2025, committing up to $3.35 billion, while Vertex gained analyst support and an RNA drug succeeded in rare ALS. Covered by: biopharmadive.com, biospace.com |
#10 China Eyes Central Role On Global Biopharma Stage Published 2026-09-24 China has set specific 2026–2030 goals to strengthen its medical and pharmaceutical industries and expand its role in global biopharmaceuticals. Covered by: insights.citeline.com |
